CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway

Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance

(2019) Kun-Peng Zhu et al.   MOLECULAR THERAPY

hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway

(2019) Minghui Xue et al.   Cancer Cell International

MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1

(2019) Dapeng Wang et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers

(2019) Min Su et al.   Molecular Cancer

Cisplatin: The first metal based anticancer drug

(2019) Sumit Ghosh   BIOORGANIC CHEMISTRY

The biogenesis, biology and characterization of circular RNAs

(2019) Lasse S. Kristensen et al.   NATURE REVIEWS GENETICS

Circular RNAs in drug resistant tumors

(2019) Xin Hua et al.   BIOMEDICINE & PHARMACOTHERAPY

Circular RNAs in cancer: new insights into functions and implications in ovarian cancer

(2019) Zahra Shabaninejad et al.   Journal of Ovarian Research

MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression

(2018) Wang Jiashi et al.   Aging-US

Identification and verification of differentially expressed microRNAs and their target genes for the diagnosis of esophageal cancer

(2018) Xiaoyue Cai et al.   Oncology Letters

MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6

(2018) Lina Wu et al.   CELL BIOLOGY INTERNATIONAL

Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β‑catenin signaling pathway

(2018) Hongfei Zhang et al.   Oncology Letters

Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway

(2018) Shengting Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis

(2016) Yanjie Lu et al.   Oncology Letters

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

(2015) Guoyan Liu et al.   JNCI-Journal of the National Cancer Institute

A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis

(2015) Branden S Moriarity et al.   NATURE GENETICS

Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers

(2015) Guoyan Liu et al.   JNCI-Journal of the National Cancer Institute

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Molecular mechanisms of chemoresistance in osteosarcoma (Review)

(2014) HONGTAO HE et al.   Oncology Letters

Natural RNA circles function as efficient microRNA sponges

(2013) Thomas B. Hansen et al.   NATURE

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Cisplatin resistance: Preclinical findings and clinical implications

(2010) Beate Köberle et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER